Starling Oncology, Inc. STLN
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +83.43%
- 1 year
- +42.27%
- Open
- 6.49
- Prev close
- 6.65
- Mkt cap
- 665.51M
- Vol
- 1.42M
- Avg vol
- 1.36M
- EPS
- -0.29
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.35
- High
- 6.69
5D chart
Signals (83)
| Name | Time | Ago |
|---|---|---|
| RSI: Oversold | Oct 30, 10:05 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:30 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:30 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 1 day ago |
| RSI: Oversold | Oct 30, 9:30 AM | 1 day ago |
| SMA: Bullish | Oct 29, 3:50 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:50 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 2:50 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 11:35 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:05 AM | 2 days ago |
| SMA: Bearish | Oct 29, 11:00 AM | 2 days ago |
| RSI: Overbought | Oct 29, 10:00 AM | 2 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:55 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:40 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:00 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 1:20 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:15 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:05 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:00 PM | 3 days ago |
| SMA: Bearish | Oct 28, 11:40 AM | 3 days ago |
| SMA: Bullish | Oct 28, 11:30 AM | 3 days ago |
| SMA: Bearish | Oct 28, 11:25 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:25 AM | 3 days ago |
| RSI: Overbought | Oct 28, 11:00 AM | 3 days ago |
| RSI: Overbought | Oct 28, 10:40 AM | 3 days ago |
| SMA: Bullish | Oct 28, 10:30 AM | 3 days ago |
| RSI: Overbought | Oct 28, 9:55 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 9:45 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:35 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:35 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 27, 3:55 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:55 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:40 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 3:20 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:05 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:55 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 2:45 PM | 4 days ago |
| RSI: Overbought | Oct 27, 2:10 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 2:05 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:00 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 1:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:25 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 1:15 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 12:50 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:35 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:35 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:30 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:25 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:20 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:15 PM | 4 days ago |
| SMA: Bullish | Oct 27, 11:45 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 11:30 AM | 4 days ago |
| SMA: Bearish | Oct 27, 11:10 AM | 4 days ago |
| SMA: Bearish | Oct 27, 10:15 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 9:30 AM | 4 days ago |
| RSI: Oversold | Oct 26, 3:45 PM | 5 days ago |
| RSI: Oversold | Oct 26, 3:35 PM | 5 days ago |
| RSI: Oversold | Oct 26, 3:25 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 3:15 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:50 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:45 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:40 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:20 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 2:10 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 1:45 PM | 5 days ago |
| RSI: Oversold | Oct 26, 1:45 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:35 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 12:20 PM | 5 days ago |
| RSI: Oversold | Oct 26, 12:20 PM | 5 days ago |
| RSI: Oversold | Oct 26, 12:00 PM | 5 days ago |
| RSI: Oversold | Oct 26, 11:50 AM | 5 days ago |
| SMA: Bullish | Oct 26, 11:25 AM | 5 days ago |
News
5 days ago globenewswire.com
Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call
CERRITOS, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (“STLN”) (NASDAQ: STLN) a pioneer in value-based community oncology care, today announced that the company will release its…
-
2 weeks ago benzinga.com
Needham Maintains Buy on Starling Oncology, Raises Price Target to $9
Needham analyst Matthew Shea maintains Starling Oncology (NASDAQ:STLN) with a Buy and raises the price target from $7 to $9.
2 weeks ago defenseworld.net
Oncology Institute (NASDAQ:STLN) Shares Climb 6.1% – Should You Buy?
Shares of Oncology Institute, Inc. (NASDAQ: STLN - Get Free Report) were up 6.1% on Friday. The stock traded as high as $6.56 and last traded at $6.56. Approximately 133,504 shares changed hands…
3 weeks ago seekingalpha.com
Cedar Grove Capital Q3 2026 Portfolio Update
During the quarter, we closed our long positions in MTY Food Group, uniQure, ClearPoint Neuro, and Suja Life Inc. During the quarter, we closed short positions in Bending Spoons SpA, Chipotle Mexican…
1 month ago globenewswire.com
Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation
Physician leaders share clinical insights on value-based therapy delivery, clinical trial access and integrated behavioral health in community oncology at major industry forums Physician leaders…
1 month ago seekingalpha.com
Starling Oncology: Improving Cash Flow And Gross Profit Fuel A Re-Rating
Starling Oncology is rated BUY, supported by strong secular growth and expanding adoption of its oncology managed care services. STLN's revenue model leverages scalable delegation contracts, driving…
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Aardvark Therapeutics (NASDAQ:AARD) shares increased by 8.5% to $6.28 during Friday's after-market session. The market value of their outstanding shares is at $144.8 million. TransCode…
2 months ago globenewswire.com
Starling Oncology to Participate in Wells Fargo Healthcare Conference
CERRITOS, Calif., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™, Inc. (NASDAQ: STLN), (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States,…
2 months ago globenewswire.com
Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale
CERRITOS, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™ Inc. (NASDAQ: STLN), (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States,…
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out…
2 months ago seekingalpha.com
Starling Oncology, Inc. (STLN) Q2 2026 Earnings Call Transcript
Starling Oncology, Inc. (STLN) Q2 2026 Earnings Call Transcript
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The market value of their outstanding shares is at $3.7 billion. As per the news, the Q1 earnings report…
2 months ago zacks.com
The Oncology Institute, Inc. (STLN) Reports Q2 Loss, Tops Revenue Estimates
The Oncology Institute, Inc. (STLN) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.14 per share a year ago.
2 months ago globenewswire.com
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States,…